| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109812A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109811A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109800A1 Novel cdk inhibitors having flavone structure |
| 06/27/2001 | EP1109799A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 06/27/2001 | EP1109796A1 Telomerase inhibitors and methods of their use |
| 06/27/2001 | EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109583A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
| 06/27/2001 | EP1109582A1 Methods to enhance and confine expression of genes |
| 06/27/2001 | EP1109578A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
| 06/27/2001 | EP1109570A2 Method of modulating memory effector t-cells and compositions |
| 06/27/2001 | EP1109569A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109555A1 Novel angiogenesis inhibitors |
| 06/27/2001 | EP1109552A1 Novel dna-cleaving antitumor agents |
| 06/27/2001 | EP1109550A2 Novel nitrophenylaziridine compounds and their use as prodrugs |
| 06/27/2001 | EP1109547A1 New use of taxoid derivatives |
| 06/27/2001 | EP1109506A1 Improved method for targeted topical treatment of disease |
| 06/27/2001 | EP0862564A4 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 06/27/2001 | EP0797564B1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0733046B1 benzoyl guanidines, their production and their use in medicaments |
| 06/27/2001 | EP0690720B1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/27/2001 | CN1301298A Methods for prevention and treatment of cancer |
| 06/27/2001 | CN1301271A Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301260A Fumagillol derivatives and processes for preparing the same |
| 06/27/2001 | CN1301174A Method of inducing an anti-tumor response against a lung metastasis in a melanoma patient |
| 06/27/2001 | CN1301169A Adenovirus-chemotherapeutic combination for treating cancer |
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300848A Polypeptide-nagarase 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300754A Polypeptide-myb protein 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300745A Polypeptide-ring finger protein 8 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300627A Antineoplastic medicine and health-care food containing earthworm plasmin |
| 06/27/2001 | CN1300597A Composition for treating cancer by magnetic positioning and its preparing process |
| 06/27/2001 | CN1300596A Dual-nm material for treatint cancer by magnetic positioning and its preparing process |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067682C Anti-tumor compounds, pharmaceutica compositions, methods for preparation thereof and for treatment. |
| 06/27/2001 | CN1067579C Medicine for curing tumor and its preparation method |
| 06/27/2001 | CN1067566C Chinese prescription medicine for treatment of digestive tract tumour and preparation method thereof |
| 06/27/2001 | CN1067549C Water soluble gossypol preparation and method therefor |
| 06/26/2001 | US6252116 Intermediates useful in a process for synthesizing COX-2 inhibitors |
| 06/26/2001 | US6252093 Total synthesis of antitumor acylfulvenes |
| 06/26/2001 | US6252086 4-alkenyl-and 4-alkynyloxindoles |
| 06/26/2001 | US6252079 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy |
| 06/26/2001 | US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 06/26/2001 | US6251915 Administering to male warm-blooded animal anti-cancer agent comprising n-(1-methyl-1-(4-methoxyphenyl)ethyl)-3-oxo-4-aza-5.alpha. -androst-1-ene-17.beta.-carboxamide or its salt or ester |
| 06/26/2001 | US6251911 Pyrimidine derivatives and processes for the preparation thereof |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251900 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 06/26/2001 | US6251885 Treating microorganism infection, lung cancer, breast cancer or leukemia in mammal |
| 06/26/2001 | US6251884 Pharmacologically acceptable composition for inhibiting or treating liver disease or inflammatory condition of gastrointestinal tract in mammal, comprising sulfate of ursodeoxycholic acid or salt thereof, carrier |
| 06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
| 06/26/2001 | US6251870 Pharmaceutical composition for inhibiting growth of cancers |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251866 A water soluble, biocompatible polymer, a chemical agent covalently, releasably coupled to the polymer and an interleukin-2-receptor binding peptide of given sequence covalently coupled to the polymer |
| 06/26/2001 | US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251678 Mixture of virus particles, salt, histidine buffer and nonionic surfactant |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
| 06/26/2001 | US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251406 Attenuated microorganism strains and their uses |
| 06/26/2001 | US6251402 Administering human chorionic gonadotrophin (hcg) beta-core, deglycosylated hcg, deglycosylated luteinizing hormone, or a mixture thereof |
| 06/26/2001 | US6251400 Comprising limonin and/or nomilin, and a tocotrienol |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/26/2001 | CA1341261C Process for the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044808A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044300A2 Brain specific binding members |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044273A2 Receptor-selective somatostatin analogs |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044260A2 Novel purines |
| 06/21/2001 | WO2001044259A1 Purine derivatives |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |